Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Note of Thanks to Lawrence Friedman: Editor and Mentor.

Digestive diseases and sciences·2026
Same author

Matrix stiffness and stress relaxation regulate osteogenesis through histone demethylases KDM4B and KDM6B.

Molecular biology of the cell·2026
Same author

Triplet pregnancies after single blastocyst embryo transfer-how often and why do these occur?

Journal of assisted reproduction and genetics·2025
Same author

A description of a manual mechanical hysteroscopy tissue removal device for operative hysteroscopy in the office setting.

American journal of obstetrics and gynecology·2025
Same author

De novo DUOX2 expression in neutrophil subsets shapes the pathogenesis of intestinal disease.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Unilateral vulvar oedema after laparoscopy: aetiology and management of a rare complication.

BMJ case reports·2025

Related Experiment Video

Updated: Jun 28, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
05:10

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

Gastroduodenal mucosal defense.

Amy Zhu1, Jonathan Kaunitz

  • 1West Los Angeles VA Medical Center, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA.

Current Gastroenterology Reports
|November 14, 2008
PubMed
Summary
This summary is machine-generated.

The gastroduodenal mucosa has multiple defense mechanisms against injury. Recent research explores new protective agents and the genetic factors influencing ulcer formation.

More Related Videos

Profiling Luminal pH in Three-Dimensional Gastrointestinal Organoids Using Microelectrodes
08:24

Profiling Luminal pH in Three-Dimensional Gastrointestinal Organoids Using Microelectrodes

Published on: July 5, 2024

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on: May 7, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging
05:10

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

Profiling Luminal pH in Three-Dimensional Gastrointestinal Organoids Using Microelectrodes
08:24

Profiling Luminal pH in Three-Dimensional Gastrointestinal Organoids Using Microelectrodes

Published on: July 5, 2024

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
11:48

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on: May 7, 2018

Area of Science:

  • Gastroenterology and Mucosal Immunology

Background:

  • The gastroduodenal mucosa is constantly exposed to damaging agents like acid and drugs.
  • Effective defense mechanisms are crucial for maintaining mucosal integrity.

Purpose of the Study:

  • To review current understanding of gastroduodenal mucosal defense mechanisms.
  • To highlight recent advances in protective factors and ulcer formation research.

Main Methods:

  • Literature review of recent studies on mucosal defense.
  • Summary of research on proteinase-activated receptors, antioxidants, and protective peptides.
  • Inclusion of findings on genetics, age, gender, and therapeutic agents.

Main Results:

  • Multiple defense layers protect the gastroduodenal lining.
  • Emerging research focuses on proteinase-activated receptors, antioxidants, and specific protective molecules.
  • New insights into genetic influences, age/gender effects, and drug development are emerging.

Conclusions:

  • Gastroduodenal mucosal defense is complex and multifactorial.
  • Ongoing research is identifying novel protective strategies and therapeutic targets for ulcers.